A randomized controlled trial of lung ultrasound-guided therapy in heart failure (CLUSTER-HF study)
Publication date: September 2020Source: American Heart Journal, Volume 227Author(s): Diego Araiza-Garaygordobil, Rodrigo Gopar-Nieto, Pablo Martinez-Amezcua, Alejandro Cabello-López, Gabriela Alanis-Estrada, Abraham Luna-Herbert, Héctor González-Pacheco, Cynthia Paola Paredes-Paucar, Martinez Daniel Sierra-Lara, Jose Luis Briseño-De la Cruz, Hugo Rodriguez-Zanella, Marco Antonio Martinez-Rios, Alexandra Arias-Mendoza
Conclusion: In conclusion, point-of-care lung ultrasound is a helpful tool for the early rule-in of acute heart failure in ED but only partially suitable for exclusion. Of note, the present study shows no significant changes in the number of B-lines after 24 and 72 h. PMID: 32731477 [PubMed - in process]
Direct, retrograde thoracic duct access is a technique that may improve the clinical success of thoracic duct embolization if the transabdominal approach is unsuccessful and may potentially obviate the need for intranodal lymphangiography with oil-based contrast agent. Minimally invasive thoracic duct interventions have become the standard of care in many institutions for chyle leaks, and future interventions may treat conditions ranging from autoimmune diseases to heart failure (1). The most common technique to access the thoracic duct is the transabdominal approach, where the cisterna chyli is cannulated in the midabdome...
ConclusionsOur results show that after a short, structured training, novice learners are able to achieve proficiency for quantifying B ‐lines on LUS after scanning 11 zones. These findings support the use of LUS for B‐line quantification by non‐physicians in clinical and research applications.
ConclusionsThe Risk ‐HF trial will evaluate the effectiveness of a risk‐guided intervention to improve HF outcomes and will evaluate the efficacy of trained HF nurses delivering a fluid management protocol that is guided by lung ultrasound with an HHU at point of care.
Background: Lymphocytopenia is associated with mortality in acute heart failure (AHF), and portal congestion has been suggested to play a role in leukocyte distribution. The associations between lymphocytopenia and ultrasound surrogates for portal congestion have never been studied. We aimed to: characterize the determinants of lymphocytopenia; explore the associations between lymphocytopenia and portal congestion; and explore the relationships between lymphocytopenia and outcomes in AHF.Methods and Results: Patients were compared according to tertiles of lymphocyte count(very low,1.2 × 109/L).
ConclusionsUp to 40% of patients considered ‘dry’ according to pulmonary auscultation presents subclinical congestion at hospital discharge that can be detected by LUS and implies a worse prognosis at 6‐ month follow‐up. Comorbidities, high values of natriuretic peptides, and higher NYHA class are the factors related with its presenc e.
After the onset of myocardial infarction, extensive coronary thrombus and oxygen supply insufficiency lead to severe myocardial damage and heart failure. Recently, ultrasound-irradiated phase-change nanoparticles have been recognized for their cardiovascular thrombolysis potential. Therefore, we sought to establish a novel treatment method using hydrogen peroxide (H2O2)/perfluoropentane (PFP) phase-change nanoparticles with low-intensity focused ultrasound (LIFU) for the simulation of acute coronary thrombolysis and myocardial preservation.
CONCLUSION: Fetuses with CAS and hydrops can be successfully treated with FAV. It has the potential to restore a sufficient fetal cardiac output, which may lead to resolution of hydrops. Surviving patients seem to be good candidates for a biventricular outcome. This article is protected by copyright. All rights reserved. PMID: 32621387 [PubMed - as supplied by publisher]
AbstractAimsWorsening of renal function (WRF) is a common complication in patients with acute decompensated heart failure (ADHF). We aimed to evaluate the role of intrarenal Doppler ultrasound (IRD) in the early prediction of WRF in this patient group.Methods and resultsAmong 90 patients (age: 57.5 ± 11.1 years; 62% male) hospitalized with ADHF, resistivity index (RI), acceleration time (AT), and pulsatility index (PI) were measured on admission and at 24 and 72 h. WRF was defined as increased serum creatinine ≥0.3 mg/dL from baseline. Adverse clinical outcomes were defined as the com po...
CONCLUSIONS: TTE can provide important information with a direct impact on the management of patients. Faced with cardiac emergencies, an adapted training can be proposed for the MP. Thereby, the transfer of conventional cardiac views could facilitate the advice of a cardiologist. PMID: 32591832 [PubMed - as supplied by publisher]